🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China flag China · Delayed Price · Currency is CNY
7.20
-0.41 (-5.39%)
Nov 20, 2026, 3:04 PM CST

SHE:301009 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,2071,1311,0581,0541,1661,170
Other Revenue
19.719.720.2827.5520.2416.19
1,2261,1501,0791,0811,1861,186
Revenue Growth
9.61%6.65%-0.27%-8.83%-0.01%-27.44%
Cost of Revenue
949.81885.19866.7900.271,043973.16
Gross Profit
276.62265.04211.84181.22143.63213.25
Selling, General & Admin
212.51194.25165.35135.44125.51127.85
Research & Development
53.6848.3645.0444.1150.9849.27
Other Operating Expenses
3.460.77-1.271.183.134.26
Operating Expenses
272.17242.67209.96177.24184.84179.32
Operating Income
4.4522.371.883.97-41.2133.92
Interest Expense
-3.63-2.26-0.73-0.65-0.28-0.96
Interest & Investment Income
29.1831.2920.7224.2523.5817.7
Currency Exchange Gain (Loss)
-14.44-14.448.725.6616.54-4.37
Other Non Operating Income (Expenses)
-25.84-1-3.18-1.56-1.22-5.63
EBT Excluding Unusual Items
-10.2735.9527.4231.67-2.5940.66
Gain (Loss) on Sale of Investments
1.380.92-0.38-3.34--
Gain (Loss) on Sale of Assets
-1-0.1-0.04-0.10.120.04
Asset Writedown
-1.48-0.01-0.21-14.09-62.3-0.16
Other Unusual Items
2.362.596.115.328.392.99
Pretax Income
-9.0139.3532.9119.45-56.3743.53
Income Tax Expense
-5.812.082.341.69-0.134.09
Earnings From Continuing Operations
-3.237.2730.5717.76-56.2539.44
Minority Interest in Earnings
-1.89-1.150.612.4213.120.31
Net Income
-5.0936.1231.1720.18-43.1339.75
Net Income to Common
-5.0936.1231.1720.18-43.1339.75
Net Income Growth
-15.87%54.44%---81.43%
Shares Outstanding (Basic)
258258260288270234
Shares Outstanding (Diluted)
258258260288270234
Shares Change
0.18%-0.69%-9.91%6.98%15.29%14.71%
EPS (Basic)
-0.020.140.120.07-0.160.17
EPS (Diluted)
-0.020.140.120.07-0.160.17
EPS Growth
-16.67%71.43%---83.81%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-46.6286.88-22.91161.69-153.6-189.92
Free Cash Flow Per Share
-0.180.34-0.090.56-0.57-0.81
Dividend Per Share
0.1200.1200.0700.075-0.070
Dividend Growth
71.43%71.43%-6.67%---
Gross Margin
22.55%23.04%19.64%16.76%12.11%17.97%
Operating Margin
0.36%1.94%0.18%0.37%-3.47%2.86%
Profit Margin
-0.41%3.14%2.89%1.87%-3.64%3.35%
Free Cash Flow Margin
-3.80%7.55%-2.12%14.95%-12.95%-16.01%
EBITDA
64.6480.2856.7557.718.5382.5
EBITDA Margin
5.27%6.98%5.26%5.33%1.56%6.95%
D&A For EBITDA
60.1957.9154.8653.7259.7448.57
EBIT
4.4522.371.883.97-41.2133.92
EBIT Margin
0.36%1.94%0.17%0.37%-3.47%2.86%
Effective Tax Rate
-5.29%7.11%8.69%-9.40%
Revenue as Reported
1,2261,1501,0791,0811,1861,186